Skip to main content

    Brad Loncar

    Brad Loncar is a prominent biotech investor and creator of BiotechTV, known for translating clinical trial data and public market biotech performance for a broader audience.

    #19 Biotech
    21CiteRank

    Last updated 11 Nov 2026 · Named in 12 answers across 5 engines
    Bing AI Mode starts a separate baseline. Copilot remains a separate public engine and keeps its history; changes across the switch are not like-for-like growth.

    How AI engines see them

    Recognized by 5 of 5 measured engines. Updated 2026-10-26

    The five engines agree that Brad Loncar is a biotech investor who ran Loncar Investments, created thematic biotech ETFs including a cancer immunotherapy fund, and later founded BiotechTV. ChatGPT centers on the Loncar Cancer Immunotherapy Index and ETF launched in 2015. Copilot and Perplexity add his earlier work at Franklin Templeton and the U.S. Treasury. Gemini and Google AI Mode add his comments on separating AI hype from substance in biotech. The cited pages come most often from biotechtv.com and rbccm.com.

    • ChatGPTNamed in 2 answers

      ChatGPT says Loncar is a biotech investor and index creator who launched the Loncar Cancer Immunotherapy Index and ETF in 2015 and argued that biotech is not one thing.

      Known for
      • Cancer Immunotherapy Index and ETF
      • thematic biotech investing
      • technology platform framing of biotech
    • GeminiNamed in 2 answers

      Gemini says Loncar is a biotech commentator and former investor who ran Loncar Investments, created Nasdaq-listed ETFs, and launched BiotechTV in 2023 for biotech news and interviews.

      Known for
      • thematic biotech indexes and ETFs
      • launching BiotechTV
      • sifting hype from substance in AI
    • Google AI ModeNamed in 4 answers

      Google AI Mode says Loncar is a biotech commentator and former investor who launched BiotechTV in June 2023 and explains techbio platforms to a broad audience.

      Known for
      • launching BiotechTV
      • creating biotech ETFs
      • chronicling the techbio shift
    • PerplexityNamed in 1 answers

      Perplexity says Loncar is a biotech communicator and former thematic investor who created cancer immunotherapy and China biopharma ETFs and founded BiotechTV in June 2023.

      Known for
      • cancer immunotherapy and China biopharma ETFs
      • founding BiotechTV
      • translating biotech for a broad audience
    • Bing AI ModeNot named

      No description yet.

    • CopilotNamed in 3 answers

      Copilot says Loncar is a biotech investor turned media entrepreneur who founded BiotechTV, created two Nasdaq-listed biotech ETFs and comments on AI hype in biotech.

      Known for
      • founding BiotechTV
      • creating two biotech ETFs
      • separating AI hype from breakthroughs

    Top Segments

    • #19Biotechof 66
      Named in 28 answers

    Top URLs

    1. 1
      Top 20 Biotech Voices to Follow in 2026 | Jack Shuang Hou posted on the topic | LinkedIn
      linkedin.com9 citations
    2. 2
      Profiles of Global Pharmaceutical Industry Leaders | IntuitionLabs
      intuitionlabs.ai3 citations
    3. 3
      Top 100 Biotech Influencers in 2026
      x.feedspot.com3 citations

    Prompts where Brad is named

    Run now opens the answer page for that prompt.

    • Who should I follow to learn about Synthetic biology experts and influencers?

      Named by 1 engines

    Track Brad

    Follow Brad's measured AI visibility and see the questions where they rank.